Results 281 to 290 of about 376,311 (300)

Immunogenicity and safety of an investigational hepatitis B vaccine with a Toll-like receptor 9 agonist adjuvant (HBsAg-1018) compared to a licensed hepatitis B vaccine in healthy adults 40-70 years of age.

Vaccine, 2013
W. Heyward, Michael Kyle, Joseph Blumenau, Matthew G Davis, K. Reisinger, M. L. Kabongo, Sean Bennett, R. Janssen, H. Namini, J. Martin   +9 more
semanticscholar   +1 more source

Human papillomavirus vaccination guideline update: American Cancer Society guideline endorsement

Ca-A Cancer Journal for Clinicians, 2016
Lacey Loomer Msph, Robert A Smith
exaly  

Hepatitis B Vaccine

DICP, 1991
openaire   +2 more sources

Hepatitis B vaccines

Vaccine, 1984
openaire   +4 more sources

The importance of immunization in cancer prevention, treatment, and survivorship

Ca-A Cancer Journal for Clinicians, 2017
Christopher R Flowers, Ted Gansler, Saad B Omer   +2 more
exaly  

Immunological considerations for COVID-19 vaccine strategies

Nature Reviews Immunology, 2020
Fiona Smaill, Matthew S Miller, Brian Dennis Lichty   +2 more
exaly  

Hepatitis B Vaccine

The Lancet, 1980
H. C. Thomas, William F. Carman
semanticscholar   +1 more source

Aerosolized PLA and PLGA nanoparticles enhance humoral, mucosal and cytokine responses to hepatitis B vaccine.

Molecular Pharmaceutics, 2011
Chandan Thomas, A. Rawat, L. Hope-weeks, F. Ahsan   +3 more
semanticscholar   +1 more source

Universal hepatitis B vaccination

The Lancet Infectious Diseases, 2008
openaire   +4 more sources

A novel therapeutic hepatitis B vaccine induces cellular and humoral immune responses and breaks tolerance in hepatitis B virus (HBV) transgenic mice.

Vaccine, 2013
P. Buchmann, Claudia J. Dembek, Larissa Kuklick, C. Jäger, R. Tedjokusumo, Miriam John von Freyend, U. Drebber, Zbigniew Janowicz, K. Melber, U. Protzer   +9 more
semanticscholar   +1 more source